ClinicalTrials.gov term: Precursor Cell Lymphoblastic Leukemia-Lymphoma
51 trials changed in the last 30 days: 5 stopped, 18 with notable changes, 28 with minor changes only.
Trial terminated
Also in this update: Primary completion date changed from estimate of Dec 31, 2025 to Apr 21, 2026; Final enrollment: 49 participants (planned 124)
Maria Sklodowska-Curie National Research Institute of OncologyPhase 2 NCT04920968 Registry history of NCT04920968 on ClinicalTrials.gov (opens the registry)
Recruitment suspended
City of Hope Medical CenterPhase 1 NCT06195891 Registry history of NCT06195891 on ClinicalTrials.gov (opens the registry)
Trial status changed: Not Yet Recruiting → Suspended
M.D. Anderson Cancer CenterPhase 2 NCT07192237 Registry history of NCT07192237 on ClinicalTrials.gov (opens the registry)
Trial status changed: Not Yet Recruiting → Terminated
Also in this update: Primary completion date changed from estimate of Jul 31, 2026 to Aug 31, 2026; Final enrollment: 49 participants (planned 124)
Gadjah Mada UniversityPhase 4 NCT07320534 Registry history of NCT07320534 on ClinicalTrials.gov (opens the registry)
Recruitment suspended
University of WashingtonPhase 2 NCT06738368 Registry history of NCT06738368 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Mar 1, 2027 to Nov 1, 2027
Also in this update: Study completion pushed from Aug 2027 to Apr 1, 2028
Alliance for Clinical Trials in OncologyPhase 3 NCT03150693 Registry history of NCT03150693 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 5, 2028 to Mar 6, 2031
Also in this update: Study completion pushed from Jun 18, 2030 to Sep 16, 2032
AmgenPhase 1/2 NCT07134088 Registry history of NCT07134088 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 13, 2028 to Jun 9, 2029
City of Hope Medical CenterPhase 1 NCT07040982 Registry history of NCT07040982 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 2033 to Jan 2034
Also in this update: Primary endpoint(s) modified; Enrollment reduced: 100 → 50 participants
Guenther KoehnePhase 2 NCT05565105 Registry history of NCT05565105 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 1, 2026 to Aug 1, 2027
Also in this update: Study completion pushed from Aug 1, 2027 to Aug 1, 2028
British Columbia Cancer AgencyPhase 1 NCT06208735 Registry history of NCT06208735 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 31, 2026 to Oct 31, 2028
M.D. Anderson Cancer CenterPhase 2 NCT00501826 Registry history of NCT00501826 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 22, 2026 to Sep 21, 2027
City of Hope Medical CenterPhase 1 NCT05707273 Registry history of NCT05707273 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Nov 15, 2028 to Jul 29, 2031
H. Lee Moffitt Cancer Center and Research InstitutePhase 2 NCT06144606 Registry history of NCT06144606 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 2026 to Sep 2027
Memorial Sloan Kettering Cancer CenterPhase 1 NCT01430390 Registry history of NCT01430390 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Sep 2027
Also in this update: Study completion pushed from Mar 2027 to Mar 2028
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsEarly Phase 1 NCT06398457 Registry history of NCT06398457 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Enrollment increased: 45 → 100 participants
St. Jude Children's Research HospitalPhase 2 NCT07790913 Registry history of NCT07790913 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Resonance, Inc.Not specified NCT07246213 Registry history of NCT07246213 on ClinicalTrials.gov (opens the registry)
Recruitment opened
Also in this update: Interventions modified
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Phase 1 NCT07616089 Registry history of NCT07616089 on ClinicalTrials.gov (opens the registry)
Enrolling by invitation only
Also in this update: Study completion pushed from Dec 2031 to Dec 2032
Minsk Scientific-Practical Center for Surgery, Transplantation and HematologyPhase 1/2 NCT07162571 Registry history of NCT07162571 on ClinicalTrials.gov (opens the registry)
Study completion date changed from estimate of Dec 31, 2025 to Sep 8, 2026
Also in this update: Trial completed
Otsuka Beijing Research InstitutePhase 2 NCT04233346 Registry history of NCT04233346 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Start date pushed from Jun 30, 2021 to Jul 22, 2021; Study completion date changed from estimate of Nov 2026 to Sep 30, 2026
CareDxNot specified NCT04635384 Registry history of NCT04635384 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Apr 28, 2028 to Oct 11, 2028
Also in this update: Study completion pushed from Jul 3, 2028 to Jul 18, 2029
AstraZenecaPhase 1/2 NCT07109219 Registry history of NCT07109219 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Sep 29, 2026 to Jul 21, 2026; Final enrollment: 6 participants (planned 10)
Janssen Research & Development, LLCPhase 1 NCT07295951 Registry history of NCT07295951 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 2026 to Nov 2026
Miltenyi Biomedicine GmbHPhase 1 NCT03853616 Registry history of NCT03853616 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion pushed from Nov 1, 2026 to Feb 1, 2027; Primary completion date changed from estimate of Nov 1, 2026 to Aug 31, 2026
Donald ArnoldNot applicable NCT06947044 Registry history of NCT06947044 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 31, 2026 to Dec 31, 2026
Northside Hospital, Inc.Phase 2 NCT05909059 Registry history of NCT05909059 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Nov 1, 2026 to Feb 1, 2027
Also in this update: Study completion pushed from Dec 1, 2026 to Jun 1, 2027
Northside Hospital, Inc.Phase 2 NCT05519579 Registry history of NCT05519579 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 27 participants (planned 34)
Karamanoğlu Mehmetbey UniversityNot applicable NCT06794762 Registry history of NCT06794762 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 23 → 27 locations
Merck Sharp & Dohme LLCPhase 2/3 NCT07570173 Registry history of NCT07570173 on ClinicalTrials.gov (opens the registry)
Trial completed
St. Jude Children's Research HospitalNot applicable NCT05550948 Registry history of NCT05550948 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 280 → 285 locations
National Cancer Institute (NCI)Phase 2 NCT03739814 Registry history of NCT03739814 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 10 → 12 participants
PfizerNot specified NCT06476665 Registry history of NCT06476665 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 11 → 14 locations
Autolus LimitedPhase 1 NCT06173518 Registry history of NCT06173518 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 11 → 16 locations
SWOG Cancer Research NetworkPhase 2 NCT06773936 Registry history of NCT06773936 on ClinicalTrials.gov (opens the registry)
Study completion moved earlier from Sep 15, 2028 to Aug 10, 2028
Also in this update: Primary completion moved earlier from Feb 11, 2028 to Jan 6, 2028
AstraZenecaPhase 1/2 NCT06137118 Registry history of NCT06137118 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 3 → 6 locations
Resonance, Inc.Not specified NCT07632014 Registry history of NCT07632014 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Aug 14, 2027 to Sep 30, 2034
Children's Oncology GroupPhase 3 NCT03007147 Registry history of NCT03007147 on ClinicalTrials.gov (opens the registry)
Study completion moved earlier from Oct 2028 to Aug 2028
Also in this update: Primary completion moved earlier from Oct 2027 to Aug 2027
University of Michigan Rogel Cancer CenterPhase 1 NCT07532525 Registry history of NCT07532525 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Jun 2027 to Jun 2040
Also in this update: Primary completion date changed from estimate of Jun 2027 to Jul 17, 2025
Stanford UniversityPhase 1Unusual date NCT05993949 Registry history of NCT05993949 on ClinicalTrials.gov (opens the registry)
Study completion pushed from May 23, 2026 to May 23, 2027
Baylor College of MedicineNot applicable NCT05236764 Registry history of NCT05236764 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Jul 29, 2026 to Jun 28, 2027
City of Hope Medical CenterPhase 1 NCT03560752 Registry history of NCT03560752 on ClinicalTrials.gov (opens the registry)
Interventions modified
Also in this update: Trial arms changed: 3 → 4
Washington University School of MedicinePhase 1 NCT05044039 Registry history of NCT05044039 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Dec 1, 2039 to Dec 1, 2040
Also in this update: Primary completion date changed from estimate of Sep 1, 2025 to Dec 11, 2025
Benjamin TomlinsonPhase 1 NCT04732845 Registry history of NCT04732845 on ClinicalTrials.gov (opens the registry)
Study completion moved earlier from Jun 2028 to Mar 2028
Fundación para la Investigación Biosanitaria del Principado de AsturiasNot applicable NCT07597590 Registry history of NCT07597590 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
FamiCordTxPhase 1 NCT06593145 Registry history of NCT06593145 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Baseline Study LLCNot specified NCT03154346 Registry history of NCT03154346 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Institute of Hematology & Blood Diseases Hospital, ChinaNot applicable NCT06658938 Registry history of NCT06658938 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Aug 2021); last known: Recruiting
University Hospital, BrestNot specified NCT05009537 Registry history of NCT05009537 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-10-09 | NCT07867509 A Clinical Trial on the Effect of Infant Formula Consumption on Growth, Immune… | FrieslandCampina new | Phase 3 |
| 2026-10-07 | NCT07862010 Study of GI001 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and B-Cell Acute… | Hematology department of the 920th hospital new | Early Phase 1 |
| 2026-10-06 | NCT07861477 Murottal as Adjunctive Intervention in Pediatric | Universitas Airlangga new | |
| 2026-10-05 | NCT07858214 Measurement of Ocular Microtremor With the iTremor Device in a Diverse US Cohort | Head Diagnostics new | |
| 2026-09-10 | NCT07814170 A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In… | University of West Attica new | |
| 2026-09-04 | NCT07805096 Efficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and… | National Defense Medical University, Taiwan new | |
| 2026-08-31 | NCT07795099 A Single-center, Prospective, Exploratory Clinical Study | LanZhou University new | |
| 2026-08-21 | NCT07780123 Nurture by Nature Feasibility Study | Ina Olmer Specht new | |
| 2026-08-18 | NCT07770698 A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid… | BeOne Medicines new | Phase 1/2 |
| 2026-08-13 | NCT07763054 Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia… | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine new |
| Early Phase 1 | 37 | |
| Phase 1 | 154 | |
| Phase 1/2 | 106 | |
| Phase 2 | 178 | |
| Phase 2/3 | 17 | |
| Phase 3 | 41 | |
| Phase 4 | 8 |
Institute of Hematology & Blood Diseases Hospital, China (33) · City of Hope Medical Center (32) · St. Jude Children's Research Hospital (29) · M.D. Anderson Cancer Center (24) · National Cancer Institute (NCI) (24) · The First Affiliated Hospital of Soochow University (20) · Memorial Sloan Kettering Cancer Center (18) · Zhejiang University (12) · Baylor College of Medicine (11) · Children's Oncology Group (11)